DMEMEDS shared post via Reuters: U.S. healthcare profit outlook brightens on Obamacare, drug prices

NEW YORK (Reuters) - U.S. healthcare companies are winning higher profit forecasts, bucking a wider trend on Wall Street, as pricey new biotech drugs hit the market and insurance enrollment rises under the Affordable Care Act. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/LK2PeniC8mQ/story01.htm

Read More